GEV GE Vernova Inc

Dividend
0.17%
Previous close
$898.57
Est. 12 months change
-4.71%
Projected Price
$855.80

Profitability Metrics

Return on Equity (ROE)
47.38%
Return on Assets (ROA)
5.63%
Return on Invested Capital (ROIC)
28.95%
Weighted Average Cost of Capital (WACC)
11.53%
ROIC - WACC
17.41%
Updated : 2026-04-03 21:10 ET

Valuation Metrics

P/E Ratio
50.64
Forward P/E
61.99
PEG Ratio
1.56
Debt Current Ratio
0.98

Growth & Cash Flow

Gross Margin
19.94%
Operating Margin
4.64%
FCF Margin
9.75%
TTM Revenue Growth
3.77%
Projected 12M EPS Growth
-18.31%

Price Change

Price % from 50 SMA
6.94%
Price % from 200 SMA
32.59%
6 Months
48.22%
1 Year
171.64%
2 Years
541.84%
Click here to see the list of ETFs containing GEV as a top holding :GE Vernova Inc ETFs

Analysis

Company Overview

GE Vernova is a global energy company providing grid solutions, wind turbines, gas turbines, and electrification software for power generation and transmission. Sector: Industrials.

Overview

GE Vernova Inc (GEV) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 28.95%, WACC is 11.53%, and the economic spread is 17.41%. On balance, the economic spread is positive and meaningful, suggesting the company are building rather than eroding intrinsic value. Supporting metrics show ROE at 47.38% and ROA at 5.63%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Valuation

From a market pricing perspective, trailing P/E of 50.64, forward P/E of 61.99, PEG of 1.56. With trailing and forward P/E closely aligned, the market appears to be pricing the company on the assumption that earnings remain broadly stable near term. On a growth-adjusted basis, valuation appears reasonable relative to expected growth. The company carries an aggregate current ratio of 0.98, pointing to constrained near-term balance sheet coverage. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 19.94%, operating margin at 4.64%, and free cash flow margin at 9.75%. Thin gross margins leave limited room for operational leverage — cost discipline at every layer becomes critical. Operating margins this compressed indicate businesses where the path to earnings remains dependent on future scale. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

Growth & Forward Outlook

The forward view combines two signals: the estimated 12-month price change of -4.76%, where analyst assumptions imply downside unless operating trends re-accelerate, while TTM revenue growth of 3.77% indicating muted but still positive top-line momentum across the company. The forward EPS growth estimate of -18.3% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Hold

There is enough quality in the profile to avoid outright concern, but not enough uniform strength to take high conviction in a direction. Patience has merit here.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.